Biomarkers Predicting for Response and Relapse with Melanoma Systemic Therapy

por WELSH, Sarah J., CORRIE, Pippa G.
Publicado 2020

Adjuvant Therapy in Renal Cell Carcinoma—Past, Present, and Future()

por Janowitz, Tobias, Welsh, Sarah J., Zaki, Kamarul, Mulders, Peter, Eisen, Tim
Publicado 2013

Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials

por Mossop, Helen, Grayling, Michael J., Gallagher, Ferdia A., Welsh, Sarah J., Stewart, Grant D., Wason, James M. S.
Publicado 2021

Inhibition of the hypoxia-inducible factor pathway by a G-quadruplex binding small molecule

por Welsh, Sarah J., Dale, Aaron G., Lombardo, Caterina M., Valentine, Helen, de la Fuente, Maria, Schatzlein, Andreas, Neidle, Stephen
Publicado 2013

‘Know thyself’ – host factors influencing cancer response to immune checkpoint inhibitors

por Gunjur, Ashray, Manrique‐Rincón, Andrea J, Klein, Oliver, Behren, Andreas, Lawley, Trevor D, Welsh, Sarah J, Adams, David J
Publicado 2022

Stromal-driven and Amyloid β-dependent induction of neutrophil extracellular traps modulates tumor growth

por Munir, Hafsa, Jones, James O., Janowitz, Tobias, Hoffmann, Markus, Euler, Maximilien, Martins, Carla P., Welsh, Sarah J., Shields, Jacqueline D.
Publicado 2021

Multiparametric MRI for assessment of early response to neoadjuvant sunitinib in renal cell carcinoma

por Ursprung, Stephan, Priest, Andrew N., Zaccagna, Fulvio, Qian, Wendi, Machin, Andrea, Stewart, Grant D., Warren, Anne Y., Eisen, Timothy, Welsh, Sarah J., Gallagher, Ferdia A., Barrett, Tristan
Publicado 2021

A Systematic Review of Immune Checkpoint Inhibitors in Non-Clear-Cell Renal Cancer

por Palma dos Reis, Ana Filipa, Simão, Diana, Odeny, Thomas, Rodrigues, Chiara, Fontes-Sousa, Mário, da Luz, Ricardo, Chowdry, Rajasree Pia, Welsh, Sarah J., Paller, Channing, Barata, Pedro C.
Publicado 2022

Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients

por Lim, Su Yin, Lee, Jenny H., Welsh, Sarah J., Ahn, Seong Beom, Breen, Edmond, Khan, Alamgir, Carlino, Matteo S., Menzies, Alexander M., Kefford, Richard F., Scolyer, Richard A., Long, Georgina V., Rizos, Helen
Publicado 2017

A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell Carcinoma

por Voss, Martin H., Azad, Arun A., Hansen, Aaron R., Gray, Jhanelle E., Welsh, Sarah J., Song, Xuyang, Kuziora, Michael, Meinecke, Lina, Blando, Jorge, Achour, Ikbel, Wang, Yi, Walcott, Farzana L., Oosting, Sjoukje F.
Publicado 2022

Incidence, risk factors and outcomes of checkpoint inhibitor-induced liver injury: A 10-year real-world retrospective cohort study

por Atallah, Edmond, Welsh, Sarah J., O’Carrigan, Brent, Oshaughnessy, Ana, Dolapo, Igboin, Kerr, Andrew S., Kucharczak, Joanna, Lee, Colin Y.C., Crooks, Colin, Hicks, Amy, Chimakurthi, Chenchu Ramu, Rao, Ankit, Franks, Hester, Patel, Poulam M., Aithal, Guruprasad P.
Publicado 2023

The Efficacy of Sunitinib Treatment of Renal Cancer Cells Is Associated with the Protein PHAX In Vitro

por Al-Lamki, Rafia S., Hudson, Nicholas J., Bradley, John R., Warren, Anne Y., Eisen, Tim, Welsh, Sarah J., Riddick, Antony C. P., O’Mahony, Fiach C., Turnbull, Arran, Powles, Thomas, Reverter, Antonio, Harrison, David J., Stewart, Grant D.
Publicado 2020

The MITRE trial protocol: a study to evaluate the microbiome as a biomarker of efficacy and toxicity in cancer patients receiving immune checkpoint inhibitor therapy

por Thompson, Nicola A., Stewart, Grant D., Welsh, Sarah J., Doherty, Gary J., Robinson, Matthew J., Neville, B. Anne, Vervier, Kevin, Harris, Simon R., Adams, David J., Dalchau, Katy, Bruce, David, Demiris, Nikolaos, Lawley, Trevor D., Corrie, Pippa G.
Publicado 2022

Multi-site clonality analysis uncovers pervasive heterogeneity across melanoma metastases

por Rabbie, Roy, Ansari-Pour, Naser, Cast, Oliver, Lau, Doreen, Scott, Francis, Welsh, Sarah J., Parkinson, Christine, Khoja, Leila, Moore, Luiza, Tullett, Mark, Wong, Kim, Ferreira, Ingrid, Gómez, Julia M. Martínez, Levesque, Mitchell, Gallagher, Ferdia A., Jiménez-Sánchez, Alejandro, Riva, Laura, Miller, Martin L., Allinson, Kieren, Campbell, Peter J., Corrie, Pippa, Wedge, David C., Adams, David J.
Publicado 2020

The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel tr...

por Ursprung, Stephan, Mossop, Helen, Gallagher, Ferdia A., Sala, Evis, Skells, Richard, Sipple, Jamal A. N., Mitchell, Thomas J., Chhabra, Anita, Fife, Kate, Matakidou, Athena, Young, Gemma, Walker, Amanda, Thomas, Martin G., Ortuzar, Mireia Crispin, Sullivan, Mark, Protheroe, Andrew, Oades, Grenville, Venugopal, Balaji, Warren, Anne Y., Stone, John, Eisen, Tim, Wason, James, Welsh, Sarah J., Stewart, Grant D.
Publicado 2021

A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA)

por Stewart, Grant D., Welsh, Sarah J., Ursprung, Stephan, Gallagher, Ferdia A., Jones, James O., Shields, Jacqui, Smith, Christopher G., Mitchell, Thomas J., Warren, Anne Y., Bex, Axel, Boleti, Ekaterini, Carruthers, Jade, Eisen, Tim, Fife, Kate, Hamid, Abdel, Laird, Alexander, Leung, Steve, Malik, Jahangeer, Mendichovszky, Iosif A., Mumtaz, Faiz, Oades, Grenville, Priest, Andrew N., Riddick, Antony C. P., Venugopal, Balaji, Welsh, Michelle, Riddle, Kathleen, Hopcroft, Lisa E. M., Jones, Robert J.
Publicado 2022

Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors

por Smith, Christopher G., Moser, Tina, Mouliere, Florent, Field-Rayner, Johanna, Eldridge, Matthew, Riediger, Anja L., Chandrananda, Dineika, Heider, Katrin, Wan, Jonathan C. M., Warren, Anne Y., Morris, James, Hudecova, Irena, Cooper, Wendy N., Mitchell, Thomas J., Gale, Davina, Ruiz-Valdepenas, Andrea, Klatte, Tobias, Ursprung, Stephan, Sala, Evis, Riddick, Antony C. P., Aho, Tevita F., Armitage, James N., Perakis, Samantha, Pichler, Martin, Seles, Maximilian, Wcislo, Gabriel, Welsh, Sarah J., Matakidou, Athena, Eisen, Tim, Massie, Charles E., Rosenfeld, Nitzan, Heitzer, Ellen, Stewart, Grant D.
Publicado 2020

Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer

por Li, Ruoyan, Ferdinand, John R., Loudon, Kevin W., Bowyer, Georgina S., Laidlaw, Sean, Muyas, Francesc, Mamanova, Lira, Neves, Joana B., Bolt, Liam, Fasouli, Eirini S., Lawson, Andrew R.J., Young, Matthew D., Hooks, Yvette, Oliver, Thomas R.W., Butler, Timothy M., Armitage, James N., Aho, Tev, Riddick, Antony C.P., Gnanapragasam, Vincent, Welsh, Sarah J., Meyer, Kerstin B., Warren, Anne Y., Tran, Maxine G.B., Stewart, Grant D., Cortés-Ciriano, Isidro, Behjati, Sam, Clatworthy, Menna R., Campbell, Peter J., Teichmann, Sarah A., Mitchell, Thomas J.
Publicado 2022

Hyperpolarized (13)C-Pyruvate Metabolism as a Surrogate for Tumor Grade and Poor Outcome in Renal Cell Carcinoma—A Proof of Principle Study

por Ursprung, Stephan, Woitek, Ramona, McLean, Mary A., Priest, Andrew N., Crispin-Ortuzar, Mireia, Brodie, Cara R., Gill, Andrew B., Gehrung, Marcel, Beer, Lucian, Riddick, Antony C. P., Field-Rayner, Johanna, Grist, James T., Deen, Surrin S., Riemer, Frank, Kaggie, Joshua D., Zaccagna, Fulvio, Duarte, Joao A. G., Locke, Matthew J., Frary, Amy, Aho, Tevita F., Armitage, James N., Casey, Ruth, Mendichovszky, Iosif A., Welsh, Sarah J., Barrett, Tristan, Graves, Martin J., Eisen, Tim, Mitchell, Thomas J., Warren, Anne Y., Brindle, Kevin M., Sala, Evis, Stewart, Grant D., Gallagher, Ferdia A.
Publicado 2022